Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference

Rhea-AI Summary

Baudax Bio (NASDAQ:BXRX) announced that Gerri Henwood, President and CEO, will present at the H.C. Wainwright Annual Global Life Sciences Conference on May 25, 2022, at 1:30 p.m. Eastern Time in Miami, Florida. A webcast of the presentation will be available on the company's investors page and archived for 90 days. Baudax Bio focuses on innovative products for acute care, including its flagship product, ANJESO, the first intravenous COX-2 preferential NSAID for moderate to severe pain, along with a promising pipeline of neuromuscular blocking agents.

MALVERN, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for acute care settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the H.C. Wainwright Annual Global Life Sciences Conference, taking place in Miami, Florida on Wednesday, May 25, 2022, at 1:30 p.m. Eastern Time.

A webcast of the presentation will be available on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. The webcast will be archived on the company’s website for 90 days following the event.

About Baudax Bio

Baudax Bio is a pharmaceutical company focused on innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.

CONTACT:

Investor Relations Contact:

Argot Partners
Sam Martin / Kaela Ilami
(212) 600-1902
baudaxbio@argotpartners.com

Media Contact:

Argot Partners
David Rosen
(212) 600-1902
david.rosen@argotpartners.com

FAQ

When will Baudax Bio present at the H.C. Wainwright Annual Global Life Sciences Conference?

Baudax Bio will present at the conference on May 25, 2022, at 1:30 p.m. Eastern Time.

Where can I watch the Baudax Bio conference presentation?

The presentation can be viewed via a webcast on the investors section of the Baudax Bio website.

What is ANJESO by Baudax Bio?

ANJESO is the first and only 24-hour intravenous COX-2 preferential NSAID for managing moderate to severe pain.

What products are in Baudax Bio's pipeline?

Baudax Bio's pipeline includes two novel neuromuscular blocking agents and a proprietary chemical reversal agent.

How long will the Baudax Bio webcast be available?

The webcast will be archived for 90 days following the event.